Yi‐Rong Li
-
- Prostate Cancer Treatment and Research 10
- Chronic Obstructive Pulmonary Disease (COPD) Research 6
-
- Cancer, Lipids, and Metabolism 5
-
- RNA Interference and Gene Delivery 2
-
- Cancer-related Molecular Pathways 3
-
- Estrogen and related hormone effects 4
-
- Marine Sponges and Natural Products 3
-
- Chronic Disease Management Strategies 2
- Co-authors
- Peng LeeJonathan MelamedMichael J. GarabedianJian‐Jun WeiYi PengChing‐Hsiung LinSheng‐Hao LinZhengxin Wang
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Molecular and Cellular Biology (1 paper)Cancer Research (1 paper)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Yi‐Rong Li
28 papers receiving 557 citations
Peers
Comparison fields: 5 of 89
- Pulmonary and Respiratory Medicine 252
- Cancer Research 95
- Molecular Biology 311
- Health Informatics 6
- Oncology 113
Countries citing papers authored by Yi‐Rong Li
This map shows the geographic impact of Yi‐Rong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Rong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Rong Li more than expected).
Fields of papers citing papers by Yi‐Rong Li
This network shows the impact of papers produced by Yi‐Rong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Rong Li. The network helps show where Yi‐Rong Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yi‐Rong Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 32 | |
| 9 | 2022 | 11 | |
| 10 | 2021 | 16 | |
| 11 | 2020 | 8 | |
| 12 | 2020 | 24 | |
| 13 | 2017 | 12 | |
| 14 | 2013 | 33 | |
| 15 | 2012 | 33 | |
| 16 | 2010 | 27 | |
| 17 | 2008 | 73 | |
| 18 | 2008 | 6 | |
| 19 | 2008 | 59 | |
| 20 | 2005 | 26 |
About Yi‐Rong Li
Yi‐Rong Li is a scholar working on Pulmonary and Respiratory Medicine, Biotechnology and Cancer Research, having authored 32 papers that have together received 562 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (10 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Cancer, Lipids, and Metabolism (5 papers), Estrogen and related hormone effects (4 papers), Marine Sponges and Natural Products (3 papers), Cancer-related Molecular Pathways (3 papers), Chronic Disease Management Strategies (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (252 citations), Cancer Research (95 citations) and Molecular Biology (311 citations). Yi‐Rong Li has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Peng Lee, Jonathan Melamed, Michael J. Garabedian, Jian‐Jun Wei, Yi Peng, Ching‐Hsiung Lin, Sheng‐Hao Lin, Zhengxin Wang, Garrett Daniels and Chew‐Teng Kor. Their work appears in journals such as Proceedings of the National Academy of Sciences, Molecular and Cellular Biology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.